Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair!

BACKGROUND: Drug-resistant tuberculosis (DR-TB) is a global problem with only 52% reported cure rate. Extrapulmonary (EP) DR-TB poses a formidable diagnostic, therapeutic challenge. We aimed to study their clinical profile and treatment outcomes under the programmatic setting. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Unnati, Joshi, Jyotsna M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330803/
https://www.ncbi.nlm.nih.gov/pubmed/30604698
http://dx.doi.org/10.4103/lungindia.lungindia_192_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330803/
https://www.ncbi.nlm.nih.gov/pubmed/30604698
http://dx.doi.org/10.4103/lungindia.lungindia_192_18

Ejemplares similares